SignalXSignalX

Sionna Therapeutics, Inc. (SION) 8-K Current Report — March 2, 2026

Filed: March 2, 2026
Health Care
Pharmaceutical Preparations
Sionna Therapeutics, Inc. Overview

Sionna Therapeutics, Inc. (SION) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

Sionna Therapeutics, Inc. 8-K Mar 2, 2026 Event Analysis

Item 2.02 · Results of Operations and Financial Condition

  • • Full-year 2025 financial results disclosed via press release (Exhibit 99.1) dated March 2, 2026
  • • Investors should review Exhibit 99.1 for key figures including cash runway, R&D spend, and pipeline updates

Get deeper insights on Sionna Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.